Benzinga - Gainers
- Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
- OncoSec Medical Incorporated (NASDAQ: ONCS) jumped 122.7% to $2.4050 after the company requested withdrawal of registration statement. The company said it has opted not to pursue offering thereby at this time.
- HPX Corp. (NYSE: HPX) gained 51.3% to $14.96.
- Lucira Health, Inc. (NASDAQ: LHDX) gained 31% to $1.2250. Lucira Health recently announced FDA authorization for its at-home combination COVID-19 & flu test.
- Nerdy, Inc. (NYSE: NRDY) surged 29.6% to $3.2550 following better-than-expected Q4 results.
- Helbiz Inc (NASDAQ: HLBZ) rose 28.6% to $0.1786 after gaining over 21% on Tuesday.
- B&G Foods, Inc. (NYSE: BGS) jumped 27.6% to $16.17 after the company reported better-than-expected Q4 results.
- Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) gained 25.5% to $10.64 after the company reported Q4 results.
- Sarepta Therapeutics Inc (NASDAQ: SRPT) rose 23.4% to $150.73 after the company reported better-than-expected Q4 results.
- Schrödinger, Inc. (NASDAQ: SDGR) gained 19.3% to $25.91 following strong Q4 results.
- Dycom Industries, Inc. (NYSE: DY) gained 18.4% to $99.72 after the company reported better-than-expected Q4 sales results.
- China Pharma Holdings Inc (NASDAQ: CPHI) rose 17.4% to $0.0792. China Pharma recently announced a 1-for-10 reverse stock split.
- PetIQ, Inc. (NASDAQ: PETQ) gained 17% to $10.90 following Q4 results.
- Clarivate Plc (NYSE: CLVT) surged 17% to $11.85 following strong quarterly results.
- Duolingo, Inc. (NASDAQ: DUOL) rose 16.3% to $105.68 after the company reported better-than-expected Q4 results.
- OneSpan Inc. (NASDAQ: OSPN) jumped 16.3% to $15.72 following upbeat Q4 results.
- 3D Systems Corporation (NYSE: DDD) gained 16.2% to $11.38 after posting a narrower-than-expected quarterly loss.
- Amplify Energy Corp. (NYSE: AMPY) rose 15.3% to $9.66. Amplify Energy entered into $96.5 million Settlement with the shipping companies related to containerships' anchor strikes of pipeline.
- CarGurus, Inc. (NASDAQ: CARG) rose 15.3% to $19.66 following strong quarterly results.
- Puyi Inc. (NASDAQ: PUYI) gained 14.5% to $8.30.
- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) jumped 14.5% to $36.51 following Q4 results.
- Gulfport Energy Corporation (NASDAQ: GPOR) gained 13.4% to $74.98 following Q4 results.
- IVERIC bio, Inc. (NASDAQ: ISEE) jumped 13% to $23.52 following Q4 results.
- Myriad Genetics, Inc. (NASDAQ: MYGN) gained 12.4% to $21.28 after reporting strong quarterly results.
- OKYO Pharma Limited (NASDAQ: OKYO) shares gained 9.9% to $2.45. US Customs cleared OKYO Pharma's GMP packaged OK-101 drug for Phase 2 clinical trial for treating dry eye disease.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- Performance Shipping Inc. (NASDAQ: PSHG) shares tumbled 58.4% to $1.12 after the company reported pricing of $12.5 million registered direct offering of 5.556 million shares of common stock at a price of $2.25 per share.
- Xometry, Inc. (NASDAQ: XMTR) fell 40.5% to $18.08 after the company announced downbeat quarterly results.
- iHeartMedia, Inc. (NASDAQ: IHRT) fell 32% to $4.93 after the company posted Q4 results.
- Montrose Environmental Group, Inc. (NYSE: MEG) dropped 30.4% to $33.86 following weak quarterly sales.
- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) dipped 30.2% to $5.21.
- National Vision Holdings, Inc. (NASDAQ: EYE) dropped 29% to $26.50 following downbeat Q4 results.
- Novavax Inc (NASDAQ: NVAX) fell 27.6% to $6.70 after the company reported worse-than-expected Q4 results and said substantial doubt exists regarding its ability to continue as a going concern.
- FIGS, Inc. (NYSE: FIGS) dipped 24% to $6.99 after the company reported Q4 results.
- Bright Health Group, Inc. (NYSE: BHG) fell 22.4% to $0.6753 following Q4 results.
- Invitae Corporation (NYSE: NVTA) dropped 22.2% to $1.6716 following Q4 results.
- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) fell 20.8% to $0.1780. Adamis Pharmaceuticals and DMK Pharmaceuticals Corp entered into an Agreement and Plan of Merger and Reorganization.
- Marqeta Inc (NASDAQ: MQ) fell 21.1% to $4.5750 after the company reported fourth-quarter results and issued guidance for slowing growth.
- Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell 19.7% to $1.10.
- Compass, Inc. (NYSE: COMP) dropped 18.8% to $2.9301 after the company reported worse-than-expected Q4 results and issued weak Q1 guidance.
- Myers Industries, Inc. (NYSE: MYE) fell 18.4% to $21.08 following weak sales.
- Virgin Galactic Holdings, Inc. (NYSE: SPCE) dipped 16.1% to $4.8150 after the space travel company reported mixed fourth-quarter results.
- Clean Energy Fuels Corp. (NASDAQ: CLNE) fell 14.5% to $4.7850 following weak sales.
- Infobird Co., Ltd (NASDAQ: IFBD) dropped 14.3% to $0.6851. Infobird recently announced pricing of a $5 million registered direct offering,
- Catalyst Biosciences Inc (NASDAQ: CBIO) fell 13.4% to $0.2572. Catalyst Biosciences shares jumped around 24% on Tuesday after GC Biopharma signed an Asset Purchase Agreement with the company.
- Brightspire Capital Inc (NYSE: BRSP) fell 13.3% to $6.40 after the company announced an offering of 30,358,213 shares by DigitalBridge Group, Inc.
- MBIA Inc. (NYSE: MBI) dropped 13.2% to $11.97 following Q4 results.
- First Horizon Corporation (NYSE: FHN) declined 12.6% to $21.64.
- Wallbox N.V. (NYSE: WBX) fell 12.4% to $4.9614 following quarterly results.
- Cerus Corporation (NASDAQ: CERS) dipped 12.4% to $2.5050 following weak quarterly results.
- Arbe Robotics Ltd. (NASDAQ: ARBE) fell 9.7% to $6.30.
- Obseva SA (NASDAQ: OBSV) shares dropped 8.8% to $0.1259 after jumping 43% on Tuesday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.
- Beamr Imaging Ltd. (NASDAQ: BMR) shares fell 8.2% to $3.35. Beamr Imaging priced its initial public offering of 1,950,000 at a public offering price of $4.00 per share.
- AMC Entertainment Holdings Inc (NYSE: AMC) shares fell 5.2% to $6.76 after the company posted Q4 results. The company ended the quarter with available liquidity of $842.7 million and debt of $4.95 billion.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.